Quantum BioPharma Ltd. Cash Flows From Used In Investing Activities
Quantum BioPharma Ltd. (QNTM) reported Cash Flows From Used In Investing Activities of -$1.95 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-03-26
CAD
| Period end | Cash Flows From Used In Investing Activities 12 month |
|---|---|
| 2019-12-31 | -306.91K CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | -9.99M CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 9 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $350.65K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $759.07K derived: sum of 2 quarters · filed 2026-03-26 | -$602.26K derived: sum of 3 quarters · filed 2026-03-26 | -$1.95M 20-F · filed 2026-03-26 |
| 2025-09-30 | $408.42K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | -$952.91K derived: sum of 2 quarters · filed 2025-11-06 | -$2.30M 6-K · filed 2025-11-06 | -$1.06M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | -$1.36M derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | -$2.71M 6-K · filed 2025-08-07 | -$1.47M derived: sum of 3 quarters · filed 2026-03-26 | -$4.93M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | -$1.35M 6-K/A · filed 2025-06-16 | -$106.34K derived: sum of 2 quarters · filed 2026-03-26 | -$3.57M derived: sum of 3 quarters · filed 2026-03-26 | -$2.83M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | $1.24M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$2.22M derived: sum of 2 quarters · filed 2026-03-26 | -$1.48M derived: sum of 3 quarters · filed 2026-03-26 | -$1.50M 20-F · filed 2026-03-26 |
| 2024-09-30 | -$3.46M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | -$2.73M derived: sum of 2 quarters · filed 2025-11-06 | -$2.75M 6-K · filed 2025-11-06 | -$2.75M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-06-30 | $738.22K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | $716.08K 6-K · filed 2025-08-07 | $716.08K derived: sum of 3 quarters · filed 2026-03-26 | $446.50K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-03-31 | -$22.14K 6-K/A · filed 2025-06-16 | -$22.14K derived: sum of 2 quarters · filed 2026-03-26 | -$291.72K derived: sum of 3 quarters · filed 2026-03-26 | |
| 2023-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$269.58K derived: sum of 2 quarters · filed 2026-03-26 | -$269.58K 20-F · filed 2026-03-26 | |
| 2023-09-30 | -$269.58K derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | -$269.58K 6-K · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 6-K/A · filed 2024-08-19 | |||
| 2022-12-31 | $12.12M 20-F/A · filed 2025-03-31 | |||
| 2021-12-31 | $268.96K 20-F · filed 2024-04-02 | |||
| 2020-12-31 | $6.51M 20-F · filed 2023-03-31 | |||
| 2019-12-31 | -$230.89K 40-F · filed 2021-03-17 |